Endocrine Research Updates
For Medical Professionals
Report finds a variety of factors associated with successful treatment
No need to increase A1C goals to avoid daily hypoglycemic events
Part 2: Cardiovascular and renal benefits in detail
PART 1: The SOLOIST-WHF and SCORED Studies in a nutshell
Two diabetes self-management education programs find success by looking for effective ways to connect
Two Taiwanese companies report on new DFU treatments: one in phase 2, the other completed phase 3 overseas. US phase 3 trials for both are planned.
Residents in easily walkable neighborhoods, compared to car-dependent neighborhoods, were less likely to develop prediabetes after a one year follow up.
Treating those with type 1 diabetes includes paying attention to the mental and emotional well-being of patients and their families.
Three recent studies test the efficacy of incretin therapies in treating type 2 diabetes with promising results.
Patients who are dissatisfied after treatment with levothyroxine alone stand to benefit the most
Patients receiving weekly insulin had fewer hypoglycemic events in a new study
In a small study, 65% of patients who were prescribed the drug for thyroid eye disease had hearing issues
Gut microbiota can exert beneficial effects in diabetic patients by altering oxidative stress biomarkers
Pediatricians weigh in on how to talk to parents who are concerned their children's endocrine conditions put them at a higher risk for COVID-19
The treatment of transgender and gender diverse youth should be governed by the best available medical evidence, not politics.
Two recent studies suggest that lack of sleep can affect bone mass over time.
New research finds that COVID-19 can bring on diabetes in patients who were not prediabetic before infection
The updated recommendations from the America Diabetes Association focus on evolving evidence, upgraded technology and individualized care
